跳至主要内容
临床试验/NL-OMON47175
NL-OMON47175已完成不适用

Obtaining and analyzing plasmasamples from patients with non small cell lung cancer, referred for radiation treatment and/or chemotherapy - ICD

MAASTRO clinic0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Participant is willing and able to give informed consent for participation in the trial.
  • Male or female, aged 18 years or above.
  • Diagnosed with non-small cell lung cancer
  • Scheduled to receive one of the following two therapeutic strategies:
  • - Concurrent cisplatin-doublet chemotherapy and radiotherapy (minimal dose of 60 Gy in fractionated non-ablative doses) in patients with stage III NSCLC
  • - SBRT for stage I NSCLC: 54Gy in 3 fractions, 48 Gy in 4 fractions or 60 Gy in 8 or 5 fractions
  • Is able and willing to comply with all trial requirements.

排除标准

  • - Chronic use of corticosteroids, except when used as anti-emetics for chemotherapy or inhalers
  • - NSAIDs taken until 5 days before radiotherapy or during radiation (low dose Aspirin at a maximum of 160 mg/day, is allowed)
  • - Active auto-immune diseases
  • - Immunosuppressive medication

研究者

相似试验